ストックスクリーナーアプリを入手
149.31
0.30%
-0.45
Davita Inc (DVA) 最新ニュース
DaVita tops chart as the only large-cap healthcare services name rated strong buy - MSN
DaVita, Inc. Experiences Revision in Stock Evaluation Amidst Market Dynamics - Markets Mojo
Hedge Fund Moves: Can DaVita Inc continue delivering strong returnsGap Up & Trade Opportunity Analysis Reports - baoquankhu1.vn
Truist Lowers PT on DaVita Inc. (DVA), Keeps a Hold Rating - MSN
DaVita Stock: Is DVA Outperforming the Health Care Sector? - Barchart.com
DaVita Inc Stock (ISIN: US23804L1035) Gains on Value-Based Care Progress Amid Institutional Selling - AD HOC NEWS
DaVita’s Strong Operations Confront Debt Warning And Insider Selling Signals - Yahoo Finance
DaVita reports progress in value-based kidney care programs - Investing.com
DaVita's kidney care program delivered $200M in savings as quality improved - Stock Titan
Chart Watch: Will DaVita Inc stock benefit from M A2026 Big Picture & High Accuracy Swing Entry Alerts - baoquankhu1.vn
Zacks Industry Outlook Features Quest Diagnostics, DaVita, Option Care Health, and Addus HomeCare - Bitget
Zacks Industry Outlook Highlights Quest Diagnostics, DaVita, Option Care Health and Addus HomeCare - Zacks Investment Research
DaVita getting closer to key technical benchmark - MSN
DaVita Inc. stock outperforms competitors on strong trading day - MarketWatch
DaVita (DVA) Backs R1 Therapeutics with Major Investment - GuruFocus
R1 Therapeutics launches with oversubscribed $77.5 million Series A financing to advance first-in-class treatment for hyperphosphatemia in patients with chronic kidney disease - GlobeNewswire Inc.
Zacks.com featured highlights include Strategic Education, Seanergy Maritime Holdings, DaVita and FirstEnergy - Yahoo Finance
Delta Global Management LP Buys New Holdings in DaVita Inc. $DVA - MarketBeat
DaVita Mixes Strong Value Signals With Distress Score And Insider Selling - Sahm
DaVita Inc Stock (ISIN: US23804L1035) Faces Headwinds Amid Dialysis Demand Shifts and Regulatory Scr - AD HOC NEWS
DaVita Inc. stock underperforms Monday when compared to competitors - MarketWatch
DaVita Inc. Trade Ideas — LS:897914 - TradingView
DaVita Stock Sits at $151 With Analysts Pointing to a $190 High Target - TIKR.com
DaVita Stock Forms Golden Cross, Signaling Potential Bullish Breakout Ahead - Markets Mojo
DaVita Inc. $DVA Shares Acquired by Doma Perpetual Capital Management LLC - MarketBeat
Aquatic Capital Management Boosts Stake in DaVita - National Today
Aquatic Capital Management LLC Acquires 40,333 Shares of DaVita Inc. $DVA - MarketBeat
DaVita Inc. $DVA Shares Sold by Berkshire Hathaway Inc - MarketBeat
Is DaVita (DVA) Pricing Reflect Its Strong Multi‑Year Share Performance And Cash Flow Outlook - simplywall.st
DVA (DaVita) Graham Number : $N/A (As of Dec. 2025) - GuruFocus
DaVita (DVA) and Jazz Pharmaceuticals (JAZZ) Lead with Strong Bu - GuruFocus
DaVita Inc Stock (ISIN: US23804L1035) Gains Momentum on Institutional Buying and Strong Guidance - AD HOC NEWS
Jim Cramer on DaVita: "Haven’t seen that stock do that well in this long" - MSN
DaVita Inc. stock underperforms Friday when compared to competitors - MarketWatch
DaVita, Inc. Experiences Revision in Stock Evaluation Amid Market Dynamics - Markets Mojo
Te Ahumairangi Investment Management Ltd Has $9.10 Million Position in DaVita Inc. $DVA - MarketBeat
A Look At DaVita (DVA) Valuation As Analyst Concerns Clash With Bullish Ratings - simplywall.st
DaVita Inc. stock outperforms competitors despite losses on the day - MarketWatch
DAVITA INC (NYSE:DVA) Emerges as a Technical Breakout Candidate - ChartMill
Ohio Hospital Defeats DaVita's Dialysis Discrimination Suit - Law360
Are Investors Undervaluing DaVita (DVA) Right Now? - Yahoo Finance
DaVita reiterates 2025 guidance amid cyber incident and expects phosphate binders to contribute at upper end of range - MSN
DaVita Releases Annual Community Care Report, Highlights Achievements in Corporate Citizenship - CSRwire
Dimensional Fund Advisors LP Grows Holdings in DaVita Inc. $DVA - MarketBeat
WINTON GROUP Ltd Invests $5.76 Million in DaVita Inc. $DVA - MarketBeat
DaVita Inc. (DVA) Receives Top Rating Amid Healthcare Sector Pre - GuruFocus
How DaVita’s Buybacks-Driven Earnings Outlook Despite Falling Volumes Will Impact DaVita (DVA) Investors - simplywall.st
DaVita tops chart as the only large-cap healthcare services name rated Strong Buy (DVA:NYSE) - Seeking Alpha
DaVita Stock Down Despite Q1 Earnings Beat, Margins Contract - MSN
40,785 Shares in DaVita Inc. $DVA Bought by Munich Reinsurance Co Stock Corp in Munich - MarketBeat
DaVita Rethinks Kidney Care As Volumes Decline And Elara Stake Grows - Yahoo Finance
DaVita Inc. (NYSE:DVA) Q4 2025 earnings call transcript - MSN
Reassessing DaVita (DVA) Valuation After Strong Q4 2025 Earnings Beat And Upgraded Guidance - Yahoo Finance
Neuberger Berman Group LLC Has $61.50 Million Holdings in DaVita Inc. $DVA - MarketBeat
DaVita Inc. stock underperforms Tuesday when compared to competitors - MSN
DaVita Confronts Volume Pressure While Expanding Integrated Kidney Care Model - simplywall.st
Here's Why You Should Add DaVita Stock to Your Portfolio for Now - Finviz
2.07%
大文字化:
|
ボリューム (24 時間):